News + PR Wheeler Bio and Charles River Laboratories Announce Agreement to Build and Operate RightSourceSM Laboratory Read More
News + PR Wheeler Bio Announces Closing of $31 Million Series A Round Supporting its Clinical (CGMP) Drug Substance Manufacturing Facility in Oklahoma City Read More